Supreme Court rules against 340B cuts

In a victory for HANYS’ members, the U.S. Supreme Court unanimously held that HHS' harmful cuts to the 340B Drug Pricing Program are unlawful. HANYS strongly opposed the 340B cuts and filed two amicus briefs in support of the underlying litigation filed by AHA and others. You can review HANYS’ amicus brief, the Supreme Court’s decision and other related documents on HANYS’ Litigation Tracker.